AtlantiCare Debuts Robotic Nipple-Sparing Mastectomy in New Jersey

Patients in the tri-state area now have access to a minimally invasive surgical option for breast cancer treatment. AtlantiCare has become the first healthcare system in the region to utilize the da Vinci Single Port surgical system for robotic nipple-sparing mastectomies, aiming to improve both clinical outcomes and cosmetic results.

Corp and Tech·July 13, 2026·reads: 1,161

The procedure will be performed at the AtlantiCare Regional Medical Center’s Atlantic City Campus by Dr. Kay Yoon-Flannery, Chief of Women’s Oncology. Dr. Yoon-Flannery, who completed specialized training in South Korea, notes that the technique addresses the emotional weight of mastectomy by helping patients maintain their sense of self and physical quality of life.

Approved following recent FDA clearance, the da Vinci SP system requires only a single, smaller incision. This approach offers distinct advantages, including a reduced risk of complications related to skin and nipple blood flow, while potentially preserving nipple sensation. By providing a more natural aesthetic outcome during reconstruction, the system serves both those undergoing cancer treatment and high-risk patients seeking preventative surgery. This integration aligns with the broader mission of the AtlantiCare Cancer Care Institute, which leverages its affiliation with the Cleveland Clinic Cancer Institute to provide South Jersey residents with advanced multidisciplinary care and expanded access to clinical trials.